Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Authors' reply.

Tse C S, Loftus E V, Raffals L E, Gossard A A, Lightner A L

Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Aliment Pharmacol Ther. 2018 Sep;48(5):578-579. doi: 10.1111/apt.14907.

Abstract

摘要

相似文献

Aliment Pharmacol Ther. 2018 Sep;48(5):578-579. doi: 10.1111/apt.14907.

Aliment Pharmacol Ther. 2018 Sep;48(5):576-577. doi: 10.1111/apt.14858.

Aliment Pharmacol Ther. 2018 Jul;48(2):190-195. doi: 10.1111/apt.14829. Epub 2018 May 28.

Inflamm Bowel Dis. 2007 Nov;13(11):1424-9. doi: 10.1002/ibd.20196.

Aliment Pharmacol Ther. 2018 May;47(10):1423-1424. doi: 10.1111/apt.14638.

Acta Med Croatica. 2013 Apr;67(2):145-55.

Aliment Pharmacol Ther. 2018 Apr;47(7):1041-1042. doi: 10.1111/apt.14570.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):51-53. doi: 10.1016/j.cgh.2019.07.020. Epub 2019 Jul 16.

Vnitr Lek. 2014 Jul-Aug;60(7-8):630-4.

Aliment Pharmacol Ther. 2017 Mar;45(6):856-857. doi: 10.1111/apt.13968.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。